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Prediction of arrhythmic events by Wedensky modulation in patients with coronary artery disease
Purpose: Prediction of arrhythmic events (AE) has gained importance with the availability of implantable cardioverter-defibrillators (ICD), but is still imprecise. This study evaluated the novel and innovative Wedensky modulation index (WMI) as predictor of AE. Methods: In this prospective cohort, 179 patients with CAD referred for AE risk evaluation underwent baseline evaluation including measurement of R-/T-wave WMI (WMIRT) and left ventricular ejection fraction (LVEF). Two endpoints were assessed 3 years after the baseline evaluation: sudden cardiac death or appropriate ICD event (EP1) and any cardiac death or appropriate ICD event (EP2). Associations between baseline predictors (WMIRT and LVEF) and endpoints were evaluated in regression models. Results: Only 3 patients were lost to follow-up. EP1 and EP2 occurred in 24 and 27 patients, respectively. WMIRT (OR per 1 point increase for EP1 20.05, 95% CI 1.82-221.39, P=0.014, and for EP2 73.29, 95% CI 6.57-817.66, P<0.001) and LVEF (OR per 1% increase for EP1 0.94, 95% CI 0.90-0.99, P=0.013, and for EP2 0.93, 95% CI 0.89-0.97, P=0.002) were significantly associated with both endpoints. Bivariable regression revealed evidence for independent associations with the endpoints (P<0.05 for WMIRT controlled for LVEF). The combination of WMIRT ≥0.60 and LVEF ≤30% resulted in a positive predictive value of 36.4% for EP1 and 50.0% for EP2. Conclusions: WMIRT is a significant predictor of AE independent of LVEF and has potential to improve AE risk prediction. However, WMIRT should be evaluated in larger and independent samples before recommendations for clinical routine can be made. Left ventricle function, measured as LVEF, is the only accepted non-invasive stratification method in patients after myocardial infarction (MI) eligible for ICD implantation. Other, ECG-based or Holter-based techniques such as repolarization duration (QT) or dynamicity (QT/RR), and heart rate variability (HRV), may be considered to improve the risk stratification. The purpose of this study was to assess the usefulness of Holter-based parameters in the prediction of the ICD appropriate interventions in the patients with remote myocardial infarction, untreated with amiodarone, with ICD implanted as primary or secondary prevention of SCD. The study population consisted of 114 patients. All clinical data and Holter recordings were collected before ICD implantation, there were no patients treated with amiodarone. The following, Holter-based parameters, were used: number of premature ventricular contractions (PVC), the presence of nsVT episodes, standard deviation of all RR intervals (SDRR) as a measure of HRV, repolarization duration (QTc-correction with Bazett's formula) and QT/RR slope. The study population was followed for at least 2 years. The occurrence of any appropriate ICD delivered therapy was used as the endpoint of the study. Appropriate ICD intervention (ARYT) occurred in 64 patients (62 males, secondary prevention in 51 pts, LVEF: 39±12%, age: 66±9 years; ARYT+), and 50 patients were free of malignant ventricular arrhythmias during the follow-up (46 males, secondary prevention in 24 pts, LVEF: 35±8%, age: 63±8 years, ARYT-). ARYT+ patients were older (p=0.02), with ICD implanted as secondary prevention more often (p<0.001). Univariate Cox analysis revealed that the risk of ARYT was higher in older patients (HR=1.021/year, p=0.058), with ICD implanted as secondary prevention (HR=2.288, p=0.002), with dyskinesis in echocardiography (HR=1.418, p=0.085), and with: higher number of PVC (HR=1.034 per 100/recording, p=0.001), the episode of nsVT in Holter (HR=1.541, p=0.071), SDRR<70 ms (HR=1.998, p=0.032), QTc ≥452 ms (HR=8.21, p=0.001), QT/RR ≥0.205 (HR=2.58, p=0.01). In multivariate analysis SDRR<70 ms (HR=2,365, p=0,029), number of PVC (increase of 100/recording: HR=1,02, p=0,03) and QTc-E≥452 ms (HR=7,217, p=0,001), and QT/RR-E ≥0,205 (HR=1,806, p=0,02) remained independent risk factors of ARYT occurrence. Non-invasively assessed parameters, especially indices of repolarization duration and dynamicity were found to be powerful predictors of VT/VF occurrence in patients with remote myocardial infarction, untreated with amiodarone, and with ICD implanted as primary or secondary prevention.
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Electrocardiographic findings during marathon running in healthy athletes using a new telemedical approach Objective: Despite the beneficial effects of regular endurance exercise on cardiovascular mortality and morbidity, complex ventricular arrhythmias and atrial fibrillation seem to be common in elite and amateur endurance athletes. Nevertheless, data on arrhythmias during endurance exercise is sparse. Our goal was to proof the feasibility for recording electrocardiogram (ECG) during marathon running, and to compare the first hour with the last hour of running. Methods: 11 healthy, male recreational athletes were equipped with a longterm Tele-ECG with continuous recording of the heart rhythm during running a marathon. All ECG data were directly transferred via mobile network from the device to the Telemedicine center (Campus, Berlin, Germany) for a subsequent online diagnosis ("Streaming-Telemedtechnology") The recorded data was analyzed offline. Results: One runner had to be excluded due to artifact superimposed recording quality. Therefore 10 male runners were included in our study and completed a full or a half marathon. No episodes of atrial fibrillation could be detected. Two participants showed less than 10 ventricular premature beats (VPB) during running (Lown classification I). In another two athletes 15 polymorphic VPB (Lown classification IIIa) and 117 VPB (Lown classification IV b), including 8 couplets and one triplet were observed, respectively. There was no significant difference between the first and last hour of running concerning the number of ventricular premature beats (3.4±10.8 vs. 1.6±4.4, P = ns), mean heart rate (139.8±32.6 vs. 130.6±39.2 bpm, P = ns), maximal heart rate (150.0±32.3 vs. 149.4±37.1 bpm, P = ns), rate corrected QT-interval (444.3±35.7 vs. 439.2±25.2 ms, P = ns). Concerning heart rate variability (HRV), it remained unchanged during marathon running {HRV triangular index 11.2±9.9 vs. 10.9±8.5, P = ns; Standard deviation of all NN intervals (SDNN) 85.4±67.0 vs. 109.0±62.7 ms, P = ns}. Conclusion: We showed that ECG recording and immediate transmission of the signal by telemedicine during marathon running is feasible. In general, ventricular and supraventricular arrhythmias were rare during endurance sport in our athletes. In addition, there were no significant changes in ECG parameters during marathon running.
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